Gabriel Augusto Pires de Souza
Overview
Explore the profile of Gabriel Augusto Pires de Souza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brancaglion G, de Souza G, de Araujo L, Silva E, Silva L, de Lima Tana F, et al.
Braz J Microbiol
. 2025 Feb;
PMID: 39969815
Dengue virus (DENV) is an RNA virus belonging to the Flaviviridae family, comprising four antigenically distinct serotypes. Dengue is the primary arthropod-transmitted virus globally, posing a significant public health challenge,...
2.
Piva-Amaral R, de Souza G, Carlos Vilela Vieira Junior J, Froes Goulart de Castro R, Gozzi W, Neto S, et al.
Int Immunopharmacol
. 2024 Jan;
128:111523.
PMID: 38219440
Since the Orthoflavivirus zikaense (ZIKV) has been considered a risk for Zika congenital syndrome development, developing a safe and effective vaccine has become a high priority. Numerous research groups have...
3.
Goncalves R, de Souza G, de Souza Terceti M, Froes Goulart de Castro R, de Mello Silva B, Novaes R, et al.
Braz J Microbiol
. 2022 Nov;
54(1):53-68.
PMID: 36435956
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quickly spread worldwide, leading coronavirus disease 2019 (COVID-19) to hit pandemic level less than 4 months after the first official cases. Hence, the...
4.
de Souza G, Bideau M, Boschi C, Wurtz N, Colson P, Aherfi S, et al.
Front Cell Infect Microbiol
. 2022 Nov;
12:1003608.
PMID: 36339347
As new pathogens emerge, new challenges must be faced. This is no different in infectious disease research, where identifying the best tools available in laboratories to conduct an investigation can,...
5.
Bideau M, de Souza G, Boschi C, Baudoin J, Penant G, Jardot P, et al.
Front Microbiol
. 2022 Oct;
13:1003824.
PMID: 36312916
The SARS-CoV-2 pandemic started in the end of 2019 in Wuhan, China, which highlighted the scenario of frequent cross-species transmission events. From the outbreak possibly initiated by viral spill-over into...
6.
Belhaouari D, de Souza G, Lamb D, Kelly S, Goldstone J, Stegeman J, et al.
Elife
. 2022 Jul;
11.
PMID: 35801640
Viruses generally are defined as lacking the fundamental properties of living organisms in that they do not harbor an energy metabolism system or protein synthesis machinery. However, the discovery of...
7.
Omar Osman I, Garrec C, de Souza G, Zarubica A, Belhaouari D, Baudoin J, et al.
Front Cell Infect Microbiol
. 2022 May;
12:798767.
PMID: 35601094
COVID-19 is the biggest pandemic the world has seen this century. Alongside the respiratory damage observed in patients with severe forms of the disease, gastrointestinal symptoms have been frequently reported....
8.
Rodrigues J, de Souza G, Abrahao J, Amaral R, Froes Goulart de Castro R, Malaquias L, et al.
Biochim Biophys Acta Gen Subj
. 2022 Mar;
1866(5):130116.
PMID: 35227822
The field of Nanotechnology has taken a great leap in recent decades, with several products currently researched in the industrial sector and even available in the market bringing nanostructured components....
9.
de Souza G, Bideau M, Boschi C, Ferreira L, Wurtz N, Devaux C, et al.
Viruses
. 2022 Jan;
14(1).
PMID: 35062227
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) quickly spread worldwide following its emergence in Wuhan, China, and hit pandemic levels. Its tremendous incidence favoured the emergence of viral variants. The...
10.
de Souza G, Omar Osman I, Bideau M, Baudoin J, Jaafar R, Devaux C, et al.
Front Cell Infect Microbiol
. 2021 Jun;
11:639177.
PMID: 34178717
Several comorbidities, including hypertension, have been associated with an increased risk of developing severe disease during SARS-CoV-2 infection. Angiotensin II receptor blockers (ARBs) are currently some of the most widely-used...